 NEW YORK, Oct. 13, 2021 PRNewswire -- Mind Medicine MindMed Inc. NASDAQ: MNMD, NEO: MMED, DE: MMQ the Company, a leading biotech company developing psychedelic-inspired therapies, has joined the Clinical Trials Transformation Initiative CTTI to contribute in developing and driving adoption of practices that increase the quality and efficiency of clinical trials. MindMed joins CTTI as one of approximately 80 member organizations interested in advancing higher quality clinical trials and accelerating the path to new therapeutics and other medical products. 